Ritzen, Andreas,Rottlander, Mario,Khanzhin, Nikolay,Wenzel Tornoe, Christian,Watson, William Patrick,Husum Bak-Jensen, Henriette,Greve, Daniel Rodriguez
申请号：
AU2007214128
公开号：
AU2007214128B2
申请日:
2007.02.02
申请国别(地区):
AU
年份:
2012
代理人:
摘要：
The invention relates to a novel method for treating or reducing the symptoms of schizophrenia, said method comprising administering to a host in need thereof an effective amount of a compound able to selectively increase the ion flow through KCNQ potassium channels. Furthermore the invention relates to the use of selective KCNQ potassium channel openers for the preparation of a pharmaceutical composition for treating or reducing the symtoms of schizophrenia and related symptoms, disorders and diseases. Furthermore the invention relates to a method of screening for a compound, which is a selective KCNQ potassium channel opener and which is capable of having an anti-psychotic potential.
